News highlights four strong dividend stocks for investors during market sell-off

From Yahoo Finance: 2025-04-26 18:05:00

During challenging economic times, solid dividend stocks like AbbVie, Amgen, Bristol Myers Squibb, and Zoetis can fortify a portfolio. AbbVie’s revenue growth is driven by Skyrizi and Rinvoq, while Amgen’s lineup boasts over 10 blockbuster drugs. Bristol Myers is set to launch new medicines, and Zoetis is a leading animal health company with a robust portfolio.

AbbVie’s dividend program has increased payouts for 53 consecutive years, offering a 3.9% forward yield. Amgen, with a 3.5% forward yield, continues to reward shareholders with dividend increases. Bristol Myers has raised its dividend by nearly 68% over the past decade, providing a 5.1% yield. Zoetis has seen a 500% increase in payouts over the last 10 years, maintaining a dividend that won’t disappoint.

Consider the analyst team’s 10 best stock picks, excluding AbbVie, for potential monster returns. The Motley Fool’s Stock Advisor boasts an 872% average return, far outperforming the S&P 500’s 160%. Don’t miss out on the latest top 10 list by joining Stock Advisor for market-crushing outperformance.

Read more: 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off